InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the complete record of transactions filed by Runge Jeffrey W., Director. Insider active across 1 company, notably Aditx Therapeutics, Inc.. In total, 1 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €2k. Activity tracked since 1 June 2021. The latest transaction was disclosed on 1 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Jeffrey W. Runge is a Board Member at Aditx Therapeutics, Inc. In this role, he actively participates in board discussions and contributes to strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions. He is committed to promoting best governance practices and ensuring the company's sustainability.